Role of hepatic progenitor cells in nonalcoholic fatty liver disease development: Cellular cross-talks and molecular networks

International Journal of Molecular Sciences

Volumn 14, Issue 10, 2013, Pages 20112-20130

  Carpino, Guido ^a,b   Renzi, Anastasia ^a   Onori, Paolo ^a   Gaudio, Eugenio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME FORO ITALICO   (Italy)

Author keywords

Fibrogenesis; Hepatic progenitor cell; Hepatic stellate cells; Kupffer cells; Macrophages; Nonalcoholic fatty liver disease

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; INSULIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LIPID; NOTCH RECEPTOR; PLATELET DERIVED GROWTH FACTOR; RESISTIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; WNT PROTEIN;

ATHEROSCLEROSIS; CELL ACTIVATION; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FIBROGENESIS; HEPATIC STEM CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; INSULIN RESISTANCE; KUPFFER CELL; LIVER CELL; LIVER CELL DAMAGE; LIVER FIBROSIS; MACROPHAGE; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; STELLATE CELL; STEM CELL; WNT SIGNALING PATHWAY;

DISEASE PROGRESSION; FATTY LIVER; FIBROSIS; HUMANS; LIVER; STEM CELLS;

EID: 84885367185     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141020112     Document Type: Review

References (95)

1. Angulo, P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 2002, 346, 1221-1231.
2. Gaudio, E.; Nobili, V.; Franchitto, A.; Onori, P.; Carpino, G. Nonalcoholic fatty liver disease and atherosclerosis. Intern. Emerg. Med. 2012, 7, S297-S305.
3. Alisi, A.; Locatelli, M.; Nobili, V. Nonalcoholic fatty liver disease in children. Curr. Opin. Clin. Nutr. Metab. Care 2010, 13, 397-402.
4. Bieghs, V.; Rensen, P.C.; Hofker, M.H.; Shiri-Sverdlov, R. NASH and atherosclerosis are two aspects of a shared disease: Central role for macrophages. Atherosclerosis 2012, 220, 287-293.
5. Sookoian, S.; Gianotti, T.F.; Rosselli, M.S.; Burgueno, A.L.; Castano, G.O.; Pirola, C.J. Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease. Atherosclerosis 2011, 218, 378-385.
6. Brunt, E.M.; Kleiner, D.E.; Wilson, L.A.; Belt, P.; Neuschwander-Tetri, B.A. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: Distinct clinicopathologic meanings. Hepatology 2011, 53, 810-820.
7. Kleiner, D.E.; Brunt, E.M.; van Natta, M.; Behling, C.; Contos, M.J.; Cummings, O.W.; Ferrell, L.D.; Liu, Y.C.; Torbenson, M.S.; Unalp-Arida, A.; et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41, 1313-1321.
8. Brunt, E.M. Nonalcoholic steatohepatitis: Definition and pathology. Semin. Liver Dis. 2001, 21, 3-16.
9. Brunt, E.M. Pathology of nonalcoholic steatohepatitis. Hepatol. Res. 2005, 33, 68-71.
10. Falck-Ytter, Y.; Younossi, Z.M.; Marchesini, G.; McCullough, A.J. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin. Liver Dis. 2001, 21, 17-26.
11. Brunt, E.M. Pathology of nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 2010, 7, 195-203.
12. Lee, U.E.; Friedman, S.L. Mechanisms of hepatic fibrogenesis. Best Pract. Res. Clin. Gastroenterol. 2011, 25, 195-206.
13. Friedman, S.L. Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 2008, 88, 125-172.
14. Blaner, W.S.; O'Byrne, S.M.; Wongsiriroj, N.; Kluwe, J.; D'Ambrosio, D.M.; Jiang, H.; Schwabe, R.F.; Hillman, E.M.; Piantedosi, R.; Libien, J. Hepatic stellate cell lipid droplets: A specialized lipid droplet for retinoid storage. Biochim. Biophys. Acta 2009, 1791, 467-473.
15. Carotti, S.; Morini, S.; Corradini, S.G.; Burza, M.A.; Molinaro, A.; Carpino, G.; Merli, M.; de Santis, A.; Muda, A.O.; Rossi, M.; et al. Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C. Liver Transpl. 2008, 14, 806-814.
16. Carpino, G.; Morini, S.; Ginanni Corradini, S.; Franchitto, A.; Merli, M.; Siciliano, M.; Gentili, F.; Onetti Muda, A.; Berloco, P.; Rossi, M.; et al. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. Dig. Liver Dis. 2005, 37, 349-356.
17. Carpino, G.; Franchitto, A.; Morini, S.; Corradini, S.G.; Merli, M.; Gaudio, E. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study. Ital. J. Anat. Embryol. 2004, 109, 225-238.
18. Fujii, H.; Kawada, N. Inflammation and fibrogenesis in steatohepatitis. J. Gastroenterol. 2012, 47, 215-225.
19. Tsukamoto, H.; She, H.; Hazra, S.; Cheng, J.; Miyahara, T. Anti-adipogenic regulation underlies hepatic stellate cell transdifferentiation. J. Gastroenterol. Hepatol. 2006, 21, S102-S105.
20. Tsukamoto, H.; Zhu, N.L.; Asahina, K.; Mann, D.A.; Mann, J. Epigenetic cell fate regulation of hepatic stellate cells. Hepatol. Res. 2011, 41, 675-682.
21. Aziz-Seible, R.S.; McVicker, B.L.; Kharbanda, K.K.; Casey, C.A. Cellular fibronectin stimulates hepatocytes to produce factors that promote alcohol-induced liver injury. World J. Hepatol. 2011, 3, 45-55.
22. Pellicoro, A.; Ramachandran, P.; Iredale, J.P. Reversibility of liver fibrosis. Fibrogenesis Tissue Repair 2012, 5, S26.
23. Guy, C.D.; Suzuki, A.; Zdanowicz, M.; Abdelmalek, M.F.; Burchette, J.; Unalp, A.; Diehl, A.M. Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease. Hepatology 2012, 55, 1711-1721.
24. Xie, G.; Karaca, G.; Swiderska-Syn, M.; Michelotti, G.A.; Kruger, L.; Chen, Y.; Premont, R.T.; Choi, S.S.; Diehl, A.M. Cross-talk between notch and hedgehog regulates hepatic stellate cell fate. Hepatology 2013, doi:10.1002/hep.26511.
25. Marra, F.; Aleffi, S.; Bertolani, C.; Petrai, I.; Vizzutti, F. Adipokines and liver fibrosis. Eur. Rev. Med. Pharmacol. Sci. 2005, 9, 279-284.
26. Seki, E.; Brenner, D.A. Toll-like receptors and adaptor molecules in liver disease: Update. Hepatology 2008, 48, 322-335.
27. Vespasiani-Gentilucci, U.; Carotti, S.; Onetti-Muda, A.; Perrone, G.; Ginanni-Corradini, S.; Latasa, M.U.; Avila, M.A.; Carpino, G.; Picardi, A.; Morini, S. Toll-like receptor-4 expression by hepatic progenitor cells and biliary epithelial cells in HCV-related chronic liver disease. Mod. Pathol. 2012, 25, 576-589.
28. Kaji, K.; Yoshiji, H.; Kitade, M.; Ikenaka, Y.; Noguchi, R.; Shirai, Y.; Aihara, Y.; Namisaki, T.; Yoshii, J.; Yanase, K.; et al. Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 300, G1094-G1104.
29. Marra, F.; Aleffi, S.; Bertolani, C.; Petrai, I.; Vizzutti, F. Review article: The pathogenesis of fibrosis in non-alcoholic steatohepatitis. Aliment. Pharmacol. Ther. 2005, 22, 44-47.
30. Schwimmer, J.B.; Behling, C.; Newbury, R.; Deutsch, R.; Nievergelt, C.; Schork, N.J.; Lavine, J.E. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 2005, 42, 641-649.
31. Neuschwander-Tetri, B.A. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites. Hepatology 2010, 52, 774-788.
32. Kaplowitz, N. Mechanisms of liver cell injury. J. Hepatol. 2000, 32, 39-47.
33. Tilg, H.; Diehl, A.M. Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med. 2000, 343, 1467-1476.
34. Alkhouri, N.; de Vito, R.; Alisi, A.; Yerian, L.; Lopez, R.; Feldstein, A.E.; Nobili, V. Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease. J. Hepatol. 2012, 57, 1312-1318.
35. Carter-Kent, C.; Yerian, L.M.; Brunt, E.M.; Angulo, P.; Kohli, R.; Ling, S.C.; Xanthakos, S.A.; Whitington, P.F.; Charatcharoenwitthaya, P.; Yap, J.; et al. Nonalcoholic steatohepatitis in children: A multicenter clinicopathological study. Hepatology 2009, 50, 1113-1120.
36. Skoien, R.; Richardson, M.M.; Jonsson, J.R.; Powell, E.E.; Brunt, E.M.; Neuschwander-Tetri, B.A.; Bhathal, P.S.; Dixon, J.B.; O'Brien, P.E.; Tilg, H.; et al. Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways. Liver Int. 2013, 33, 624-632.
37. Clouston, A.D.; Powell, E.E.; Walsh, M.J.; Richardson, M.M.; Demetris, A.J.; Jonsson, J.R. Fibrosis correlates with a ductular reaction in hepatitis C: Roles of impaired replication, progenitor cells and steatosis. Hepatology 2005, 41, 809-818.
38. Nobili, V.; Carpino, G.; Alisi, A.; Franchitto, A.; Alpini, G.; de Vito, R.; Onori, P.; Alvaro, D.; Gaudio, E. Hepatic progenitor cells activation, fibrosis and adipokines production in pediatric nonalcoholic fatty liver disease. Hepatology 2012, 56, 2142-2153.
39. Richardson, M.M.; Jonsson, J.R.; Powell, E.E.; Brunt, E.M.; Neuschwander-Tetri, B.A.; Bhathal, P.S.; Dixon, J.B.; Weltman, M.D.; Tilg, H.; Moschen, A.R.; et al. Progressive fibrosis in nonalcoholic steatohepatitis: Association with altered regeneration and a ductular reaction. Gastroenterology 2007, 133, 80-90.
40. Gaudio, E.; Carpino, G.; Cardinale, V.; Franchitto, A.; Onori, P.; Alvaro, D. New insights into liver stem cells. Dig. Liver Dis. 2009, 41, 455-462.
41. Roskams, T.A.; Theise, N.D.; Balabaud, C.; Bhagat, G.; Bhathal, P.S.; Bioulac-Sage, P.; Brunt, E.M.; Crawford, J.M.; Crosby, H.A.; Desmet, V.; et al. Nomenclature of the finer branches of the biliary tree: Canals, ductules, and ductular reactions in human livers. Hepatology 2004, 39, 1739-1745.
42. Alison, M.R.; Golding, M.H.; Sarraf, C.E. Pluripotential liver stem cells: Facultative stem cells located in the biliary tree. Cell Prolif. 1996, 29, 373-402.
43. Cai, X.; Zhai, J.; Kaplan, D.E.; Zhang, Y.; Zhou, L.; Chen, X.; Qian, G.; Zhao, Q.; Li, Y.; Gao, L.; et al. Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma. Hepatology 2012, 56, 1804-1816.
44. Gouw, A.S.; Clouston, A.D.; Theise, N.D. Ductular reactions in human liver: Diversity at the interface. Hepatology 2011, 54, 1853-1863.
45. Mancino, M.G.; Carpino, G.; Onori, P.; Franchitto, A.; Alvaro, D.; Gaudio, E. Hepatic "stem" cells: State of the art. Ital. J. Anat. Embryol. 2007, 112, 93-109.
46. Huch, M.; Dorrell, C.; Boj, S.F.; van Es, J.H.; Li, V.S.; van de Wetering, M.; Sato, T.; Hamer, K.; Sasaki, N.; Finegold, M.J.; et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature 2013, 494, 247-250.
47. Cardinale, V.; Wang, Y.; Carpino, G.; Alvaro, D.; Reid, L.; Gaudio, E. Multipotent stem cells in the biliary tree. Ital. J. Anat. Embryol. 2010, 115, 85-90.
48. Carpino, G.; Cardinale, V.; Onori, P.; Franchitto, A.; Berloco, P.B.; Rossi, M.; Wang, Y.; Semeraro, R.; Anceschi, M.; Brunelli, R.; et al. Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: An anatomical in situ study yielding evidence of maturational lineages. J. Anat. 2012, 220, 186-199.
49. Boulter, L.; Govaere, O.; Bird, T.G.; Radulescu, S.; Ramachandran, P.; Pellicoro, A.; Ridgway, R.A.; Seo, S.S.; Spee, B.; van Rooijen, N.; et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat. Med. 2012, 18, 572-579.
50. Boulter, L.; Lu, W.Y.; Forbes, S.J. Differentiation of progenitors in the liver: A matter of local choice. J. Clin. Invest. 2013, 123, 1867-1873.
51. Furuyama, K.; Kawaguchi, Y.; Akiyama, H.; Horiguchi, M.; Kodama, S.; Kuhara, T.; Hosokawa, S.; Elbahrawy, A.; Soeda, T.; Koizumi, M.; et al. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat. Genet. 2011, 43, 34-41.
52. Fausto, N. Liver regeneration and repair: Hepatocytes, progenitor cells, and stem cells. Hepatology 2004, 39, 1477-1487.
53. Malato, Y.; Naqvi, S.; Schurmann, N.; Ng, R.; Wang, B.; Zape, J.; Kay, M.A.; Grimm, D.; Willenbring, H. Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. J. Clin. Invest. 2011, 121, 4850-4860.
54. Carpentier, R.; Suner, R.E.; van Hul, N.; Kopp, J.L.; Beaudry, J.B.; Cordi, S.; Antoniou, A.; Raynaud, P.; Lepreux, S.; Jacquemin, P.; et al. Embryonic ductal plate cells give rise to cholangiocytes, periportal hepatocytes, and adult liver progenitor cells. Gastroenterology 2011, 141, 1432-1438.
55. Theise, N.D.; Dolle, L.; Kuwahara, R. Low hepatocyte repopulation from stem cells: A matter of hepatobiliary linkage not massive production. Gastroenterology 2013, 145, 253-254.
56. Espanol-Suner, R.; Carpentier, R.; van Hul, N.; Legry, V.; Achouri, Y.; Cordi, S.; Jacquemin, P.; Lemaigre, F.; Leclercq, I.A. Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice. Gastroenterology 2012, 143, 1564-1575.
57. Clevers, H. The intestinal crypt, a prototype stem cell compartment. Cell 2013, 154, 274-284.
58. Spee, B.; Carpino, G.; Schotanus, B.A.; Katoonizadeh, A.; Vander Borght, S.; Gaudio, E.; Roskams, T. Characterisation of the liver progenitor cell niche in liver diseases: Potential involvement of Wnt and Notch signalling. Gut 2010, 59, 247-257.
59. Kodama, Y.; Hijikata, M.; Kageyama, R.; Shimotohno, K.; Chiba, T. The role of notch signaling in the development of intrahepatic bile ducts. Gastroenterology 2004, 127, 1775-1786.
60. McCright, B.; Lozier, J.; Gridley, T. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 2002, 129, 1075-1082.
61. Burke, Z.D.; Reed, K.R.; Phesse, T.J.; Sansom, O.J.; Clarke, A.R.; Tosh, D. Liver zonation occurs through a beta-catenin-dependent, c-Myc-independent mechanism. Gastroenterology 2009, 136, 2316-2324.
62. Roskams, T.; Yang, S.Q.; Koteish, A.; Durnez, A.; DeVos, R.; Huang, X.; Achten, R.; Verslype, C.; Diehl, A.M. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am. J. Pathol. 2003, 163, 1301-1311.
63. Tilg, H.; Moschen, A.R. Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis. Hepatology 2010, 52, 1836-1846.
64. Franchitto, A.; Onori, P.; Renzi, A.; Carpino, G.; Mancinelli, R.; Alvaro, D.; Gaudio, E. Expression of vascular endothelial growth factors and their receptors by hepatic progenitor cells in human liver diseases. Hepatobiliary Surg. Nutr. 2013, doi:10.3978/ j.issn.2304-3881. 2012.10.11.
65. Glaser, S.S.; Gaudio, E.; Miller, T.; Alvaro, D.; Alpini, G. Cholangiocyte proliferation and liver fibrosis. Expert Rev. Mol. Med. 2009, 11, e7.
66. Theise, N.D.; Kuwahara, R. The tissue biology of ductular reactions in human chronic liver disease. Gastroenterology 2007, 133, 350-352.
67. Omenetti, A.; Choi, S.; Michelotti, G.; Diehl, A.M. Hedgehog signaling in the liver. J. Hepatol. 2011, 54, 366-373.
68. Omenetti, A.; Porrello, A.; Jung, Y.; Yang, L.; Popov, Y.; Choi, S.S.; Witek, R.P.; Alpini, G.; Venter, J.; Vandongen, H.M.; et al. Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J. Clin. Invest. 2008, 118, 3331-3342.
69. Libbrecht, L.; Roskams, T. Hepatic progenitor cells in human liver diseases. Semin. Cell Dev. Biol. 2002, 13, 389-396.
70. Grappone, C.; Pinzani, M.; Parola, M.; Pellegrini, G.; Caligiuri, A.; DeFranco, R.; Marra, F.; Herbst, H.; Alpini, G.; Milani, S. Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats. J. Hepatol. 1999, 31, 100-109.
71. Marra, F.; DeFranco, R.; Grappone, C.; Milani, S.; Pastacaldi, S.; Pinzani, M.; Romanelli, R.G.; Laffi, G.; Gentilini, P. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: Correlation with monocyte infiltration. Am. J. Pathol. 1998, 152, 423-430.
72. Marra, F.; Romanelli, R.G.; Giannini, C.; Failli, P.; Pastacaldi, S.; Arrighi, M.C.; Pinzani, M.; Laffi, G.; Montalto, P.; Gentilini, P. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology 1999, 29, 140-148.
73. Malizia, G.; Brunt, E.M.; Peters, M.G.; Rizzo, A.; Broekelmann, T.J.; McDonald, J.A. Growth factor and procollagen type I gene expression in human liver disease. Gastroenterology 1995, 108, 145-156.
74. Kiss, A.; Schnur, J.; Szabo, Z.; Nagy, P. Immunohistochemical analysis of atypical ductular reaction in the human liver, with special emphasis on the presence of growth factors and their receptors. Liver 2001, 21, 237-246.
75. Sakaguchi, S.; Takahashi, S.; Sasaki, T.; Kumagai, T.; Nagata, K. Progression of alcoholic and non-alcoholic steatohepatitis: Common metabolic aspects of innate immune system and oxidative stress. Drug Metab. Pharmacokinet. 2011, 26, 30-46.
76. Wan, J.; Benkdane, M.; Teixeira-Clerc, F.; Bonnafous, S.; Louvet, A.; Lafdil, F.; Pecker, F.; Tran, A.; Gual, P.; Mallat, A.; et al. M2 Kupffer cells promote M1 Kupffer cell apoptosis: A protective mechanism against alcoholic and non-alcoholic fatty liver disease. Hepatology 2013, doi:10.1002/hep.26607.
77. Ley, K.; Miller, Y.I.; Hedrick, C.C. Monocyte and macrophage dynamics during atherogenesis. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 1506-1516.
78. Moore, K.J.; Tabas, I. Macrophages in the pathogenesis of atherosclerosis. Cell 2011, 145, 341-355.
79. Gordon, S.; Taylor, P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005, 5, 953-964.
80. Gordon, S.; Martinez, F.O. Alternative activation of macrophages: Mechanism and functions. Immunity 2010, 32, 593-604.
81. Hunter, M.M.; Wang, A.; Parhar, K.S.; Johnston, M.J.; van Rooijen, N.; Beck, P.L.; McKay, D.M. In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology 2010, 138, 1395-1405.
82. Olefsky, J.M.; Glass, C.K. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 2010, 72, 219-246.
83. Van Hul, N.; Lanthier, N.; Espanol Suner, R.; Abarca Quinones, J.; van Rooijen, N.; Leclercq, I. Kupffer cells influence parenchymal invasion and phenotypic orientation, but not the proliferation, of liver progenitor cells in a murine model of liver injury. Am. J. Pathol. 2011, 179, 1839-1850.
84. Ramachandran, P.; Pellicoro, A.; Vernon, M.A.; Boulter, L.; Aucott, R.L.; Ali, A.; Hartland, S.N.; Snowdon, V.K.; Cappon, A.; Gordon-Walker, T.T.; et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc. Natl. Acad. Sci. USA 2012, 109, E3186-E3195.
85. Marra, F.; Bertolani, C. Adipokines in liver diseases. Hepatology 2009, 50, 957-969.
86. Bertolani, C.; Sancho-Bru, P.; Failli, P.; Bataller, R.; Aleffi, S.; DeFranco, R.; Mazzinghi, B.; Romagnani, P.; Milani, S.; Gines, P.; et al. Resistin as an intrahepatic cytokine: Overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. Am. J. Pathol. 2006, 169, 2042-2053.
87. Lumeng, C.N.; Saltiel, A.R. Inflammatory links between obesity and metabolic disease. J. Clin. Invest. 2011, 121, 2111-2117.
88. Beier, J.I.; Guo, L.; von Montfort, C.; Kaiser, J.P.; Joshi-Barve, S.; Arteel, G.E. New role of resistin in lipopolysaccharide-induced liver damage in mice. J. Pharmacol. Exp. Ther. 2008, 325, 801-808.
89. Marra, F.; Gastaldelli, A.; Svegliati Baroni, G.; Tell, G.; Tiribelli, C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol. Med. 2008, 14, 72-81.
90. Samuel, V.T.; Shulman, G.I. Mechanisms for insulin resistance: Common threads and missing links. Cell 2012, 148, 852-871.
91. Peyrou, M.; Bourgoin, L.; Foti, M. PTEN in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and cancer. Dig. Dis. 2010, 28, 236-246.
92. Targher, G.; Day, C.P.; Bonora, E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N. Engl. J. Med. 2011, 363, 1341-1350.
93. Targher, G.; Chonchol, M.; Miele, L.; Zoppini, G.; Pichiri, I.; Muggeo, M. Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome. Semin. Thromb. Hemost. 2009, 35, 277-287.
94. Targher, G.; Bertolini, L.; Rodella, S.; Lippi, G.; Franchini, M.; Zoppini, G.; Muggeo, M.; Day, C.P. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Obesity (Silver Spring) 2008, 16, 1394-1399.
95. Day, C.P.; James, O.F. Steatohepatitis: A tale of two "hits"? Gastroenterology 1998, 114, 842-845.